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ABSTRACT 25 
Typing of Mycobacterium avium subspecies paratuberculosis strains presents a challenge 26 
since they are genetically monomorphic and traditional molecular techniques have limited 27 
discriminatory power. The recent advances and availability of whole genome sequencing has 28 
extended possibilities for the characterization of Mycobacterium avium subspecies 29 
paratuberculosis and it can provide a phylogenetic context to facilitate global epidemiology 30 
studies. In this study we developed a SNP assay based on polymerase chain reaction and 31 
restriction enzyme digestion or sequencing of the amplified product. The SNP analysis was 32 
performed using genome sequence data from 133 Mycobacterium avium subspecies 33 
paratuberculosis isolates with different genotypes from eight different host species and 34 
seventeen distinct geographic regions around the world. A total of 28402 SNPs were 35 
identified among all the isolates. The minimum number of SNPs required to distinguish 36 
between all the 133 genomes was 93 and between only the Type C isolates was 41. To reduce 37 
the number of SNPs and PCRs required we adopted an approach based on sequential 38 
detection of SNPs and a decision tree. By the analysis of 14 SNPs Mycobacterium avium 39 
subspecies paratuberculosis isolates can be characterized within 14 phylogenetic groups with 40 
a higher discriminatory power compared to MIRU-VNTR assay and other typing methods. 41 
Continuous updating of genome sequences are needed in order to better characterize new 42 
phylogenetic groups and SNP profiles. The novel SNP assay is a  discriminative, simple, 43 
reproducible method and requires only basic laboratory equipment for the large-scale global 44 
typing of Mycobacterium avium subspecies paratuberculosis isolates. 45 
 46 
  47 
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INTRODUCTION 48 
Mycobacterium avium subspecies paratuberculosis (Map) causes Johne’s disease, a chronic 49 
infectious enteritis principally of ruminants. The disease occurs worldwide and is responsible 50 
for significant losses to the livestock industry. Map also has been detected in a subset of 51 
human patients with Crohn’s disease (1) although the zoonotic role of the bacterium remains 52 
controversial.  53 
Strain typing is a prerequisite for tracing the sources of infection and for studying the 54 
epidemiology, population structure and evolutionary relationships between isolates. It can 55 
also reveal the genetic diversity underlying important phenotypic characteristics such as host 56 
specificity, pathogenicity, antibiotic resistance and virulence. Typing of Map strains presents 57 
a challenge since Map, like Mycobacterium tuberculosis, is genetically monomorphic (2). 58 
Genetic diversity among Map strains has been investigated using molecular techniques such 59 
as restriction fragment length polymorphism and IS900 analysis (IS900 RFLP) (3), pulsed-60 
field gel electrophoresis (PFGE) (4), amplified fragment length polymorphism (AFLP) 61 
analysis (5), random amplified polymorphic DNA (RAPD) analysis (6), mycobacterial 62 
interspersed repetitive unit – variable number tandem repeat (MIRU-VNTR) analysis (7) and 63 
short-sequence repeat (SSR) analysis (8). However, these techniques have limited 64 
discriminatory power when applied to Map and although this can be increased by combining 65 
complementary genotyping techniques, it is often insufficient for accurately determining 66 
relationships among isolates or global epidemiological studies (9; 10).  67 
Whole genome sequencing (WGS) provides the ultimate resolution of isolates and, unlike the 68 
techniques above, it can provide a phylogenetic context to facilitate global epidemiology 69 
studies and affirm epidemiological connections (10; 11; 12). Although WGS is becoming 70 
cheaper, it is still too expensive to be used for routine genotyping of Map isolates and 71 
requires robust data handling and analysis processes. Single nucleotide polymorphisms 72 
(SNPs) have been used successfully to type several genetically monomorphic pathogens, 73 
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including M. tuberculosis (13), Mycobacterium bovis (14), Salmonella enteritica Typhi (15) 74 
and Yersinia pestis (16). SNP assays have been used to discriminate between Map strain 75 
Types I, II and III (17; 18) and between strains derived from animal and human hosts (19). 76 
However, these assays were based on a limited number of SNPs, many of which were not 77 
informative when applied to a wider wild-type population. The purpose of this study was to 78 
develop a SNP assay that is  discriminative, practicable and reproducible for the large-scale 79 
global typing of Map isolates. Hence we developed a SNP typing method based on 80 
polymerase chain reaction (PCR) and restriction enzyme digestion, which would minimize 81 
costs and require only basic laboratory equipment. Additionally, we adopted an approach 82 
based on sequential detection of SNPs and a decision tree to reduce the number of SNPs and 83 
PCRs required. 84 
 85 
MATERIALS AND METHODS 86 
Selection of genome sequences and Map strains. Genome sequences from 133 Map isolates 87 
generated in a previous study (10) were selected for SNP and phylogenetic analyses. This 88 
panel was chosen to maximise genetic diversity and reduce phylogenetic discovery bias (2) 89 
since it comprised isolates with different genotypes (determined by multiplex PFGE and 90 
MIRU-VNTR), which were selected from 17 different countries and isolated from eight 91 
different host species. The panel also included isolates representing the major strain types that 92 
have been described previously (reviewed by 20; 21). The sequence reference numbers are 93 
given in Figures 1 and 2. The field isolates (n=26) for which genome sequence data was not 94 
available and that were used to validate the SNP assay are shown in Table 1. 95 
 96 
Preparation of genomic DNA. Genomic DNA from the UK field isolates (n=10) (Table 1) 97 
was extracted from plugs used to perform the PFGE analysis. Briefly, half of each plug was 98 
washed three times with 2 ml of Tris EDTA buffer pH 8 (10 mM Tris.Cl, 1 mM EDTA) for 99 
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10 min with shaking. After washing the plugs, 0.5-1 ml of sterile deionised water was added 100 
and the agarose was melted at 70ºC. The suspension was stored at -20ºC until required for 101 
PCR. DNA from the Portuguese field isolates (n=16) (Table 1) was extracted from pure 102 
cultures grown in Middlebrook 7H9  medium supplemented with 10% OADC (Oleic 103 
Albumin Dextrose Catalase) and 2 mg/l of mycobactin as previously described (10) using the 104 
QIAamp DNA Mini Kit (Qiagen) according to manufacturer’s instructions with minor 105 
modifications. Briefly, the bacterial suspension was centrifuged at 5000 × g for 10 min and 106 
the pellet was resuspended in 180 µl of ATL buffer. Zirconium beads (0.1 mm) were added 107 
to the mixture and mechanical disruption of the cells was performed twice with a FastPrep 108 
FP120 Bio101 bead shaker (Savant Instruments Inc., Holbrook, NY) at 6.5 msec
-1
 for 45 109 
seconds. The disrupted mixture was cooled on ice for 15 min and 20 µl of proteinase K was 110 
added. The remaining procedure was completed according to manufacturer’s instructions. 111 
The DNA was eluted with 200 µl of AE buffer and stored at -20ºC until required for PCR. 112 
 113 
SNP analysis and phylogenomics. The genome sequence of Map K10 (22; Accession 114 
number NC_002944.2) was used as the reference genome for the phylogenetic analyses. Raw 115 
genome sequence data for the Map isolates are available from the European Nucleotide 116 
Archive under accession PRJEB2204. The assembly of the reads into contigs was performed 117 
using Velvet assembler program (freely available at https://www.ebi.ac.uk/~zerbino/velvet/) 118 
and the alignment of the sequences and positioning of SNPs was executed utilising MUMmer 119 
package (freely available at http://mummer.sourceforge.net/) using Map K10 as reference 120 
sequence. SNPs were then extracted and concatenated and a phylogenetic tree was calculated 121 
using phyML (freely available at http://atgc.lirmm.fr/phyml). This phylogenetic tree was then 122 
imported into R using the ade4 package to explore the ‘paths’ which exist between the 123 
genomes. These ‘paths’ are a description of the strains which group on the same branch as the 124 
structure of the phylogenetic tree descends (i.e. all strains are included on the ‘root branch’, 125 
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which then bifurcates to include a subset of strains on one branch and the remaining strains 126 
on the other, and so on). Using these ‘paths’ to assign groups of genomes, SNPs which were 127 
shared by all strains on each branch were compiled. This data then allowed comparison of the 128 
SNPs present in reducing sized groups of genome sequences (as the tree descends through 129 
specific branches, the number of genomes remaining in each subsequent group becomes 130 
progressively smaller). This data permitted the detection of discriminating SNPs which are 131 
present in one group of sequences yet absent in others. A ‘set cover’ analysis was then 132 
performed on this dataset to calculate the minimum number of SNPs which were required to 133 
discriminate between the groups of strains at each selected level of the tree (see below). 134 
These SNPs were then selected and taken forward for validation as below. SNPs were named 135 
according to their base position in the revised Map K10 genome sequence. 136 
 137 
Set cover approximation and decision tree construction. The set cover problem asks, 138 
given a universe of elements to be covered (in this case, the universe was a series of pair-wise 139 
combinations of all genome groups), and a number of ‘sets’ which contain varying 140 
combinations of the elements to be covered (in this case, these ‘sets’ are specific SNPs which 141 
are found to discriminate between one or more of the pair-wise combinations of genome 142 
groups), what is the minimum number of sets required to cover all the elements of the 143 
universe.  In this case, the set cover asks what is the minimum number of SNPs required to 144 
‘fill’ all the pairwise combinations of genome groups.  In this way, the defined set of SNPs 145 
would discriminate between every possible pairwise combination of genome groups.  The set 146 
cover problem is a class of decision problem known to be NP-complete, meaning the time 147 
taken to reach an exact solution increases exponentially with problem size.  Due to the large 148 
number of total SNPs and genome groups to consider, we opted to use an approximation 149 
algorithm known as the greedy solution to estimate the set cover.  Greedy algorithms work by 150 
iteratively selecting the set which covers the largest number of uncovered universe elements.  151 
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The greedy approach is considered a suitable polynomial time approximation for the set 152 
cover problem.  This analysis resulted in the identification of a set of SNPs which could 153 
distinguish between all pairwise combinations of genome groups.    154 
The chosen SNPs which comprised the set cover formed the basis of the decision tree for 155 
determining group assignment of genomes, since every bifurcation of the phylogenetic tree 156 
could be discriminated by at least one SNP present in the set cover.  The structure of the 157 
phylogenetic tree was then manually investigated in light of the SNPs within the set cover to 158 
minimise the number of SNPs required to determine between phylogenetically relevant 159 
branches.  These SNPs were then validated as outlined below. 160 
 161 
SNP validation and primer design. Primers for PCR amplification of the selected SNPs 162 
were designed using the online software Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/) and the 163 
revised Map K10 genome sequence (23; Accession number AE016958.1) (Table 2). Primers 164 
were designed to be 18-20 mer with a melting temperature between 63 and 67ºC.  165 
PCR reactions were carried out in 50 µl containing 200 µM of each deoxynucleotide 166 
triphosphate (Invitrogen), 0.5 µM of each primer (Table 2), 1 U of Phusion® High- Fidelity 167 
DNA polymerase, 1× Phusion GC buffer (New England Biolabs), and 4 µl of extracted DNA 168 
(5 ng/µl). Amplification was performed in a TC-PLUS Thermal cycler (Techne) with an 169 
initial step at 98 ºC for 3 min, followed by 35 cycles at 98 ºC for 30 sec, 63-67 ºC for 30 sec 170 
(annealing temperatures provided in Table 2) and 72 ºC for 40 sec, ending with a step at 72 171 
ºC for 10 min. The amplified products were electrophoretically analysed in a 1.5% (w/v) 172 
agarose gel stained with SYBR® Safe DNA Gel Stain (Life Technologies) in 0.5× Tris-173 
Borate-EDTA (TBE) buffer. Gel electrophoresis images were acquired with an 174 
Alphaimager™ 2200 (Alpha Innotech). DNA ladder IV (Bioline) and Map K10 (positive 175 
control) were included on each gel.  176 
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Restriction endonuclease analysis of PCR products was performed according to the 177 
manufacturer’s instructions using one unit of restriction enzyme and 10 µl of amplified 178 
product in a total reaction volume of 25 µl. All restriction endonucleases were purchased 179 
from New England Biolabs (Table 2). Restricted products were detected by electrophoresis 180 
on 1.5% (w/v) agarose gels as described above. 181 
Confirmation of the presence of the SNPs was obtained by sequencing the PCR products. 182 
PCR product (40µl) was purified using QIAquick PCR purification Kit (Qiagen) according to 183 
manufacturer’s instructions. Sequencing of PCR products was carried out by Eurofins 184 
Genomics (MWG-Biotech) using the same primers used to the amplification of the 185 
fragments.  Confirmation of the presence or absence of the SNP in the expected position of 186 
the genome was achieved using Basic Local Alignment Search Tool (Blast - 187 
http://blast.ncbi.nlm.nih.gov/Blast.cgi). The phylogenetic profile for each isolate was 188 
obtained by combining the results for all SNPs. 189 
 190 
Discriminatory power of SNP-based genotyping assay. The discriminatory power of the 191 
assay was calculated using the Hunter-Gaston Discriminatory Index (HGDI), according to 192 
Hunter and Gaston (24). 193 
 194 
RESULTS 195 
The genome sequence data from 133 Map strains were compared to the reference Map strain 196 
K10 to identify SNPs. A total of 28402 SNPs were identified among all the isolates. A 197 
phylogenetic tree was generated based on the SNP analysis and distinct phylogenetic groups 198 
were identified (Figures 1 and 2), which conformed to the broadly recognised phylogenetic 199 
structure of Map (10). By using an adaptation of the ‘set cover’ problem, the minimum 200 
number of SNPs required to discriminate between all the isolates was calculated to be 93. To 201 
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refine the number of SNPs to a number manageable for routine laboratory procedures, we 202 
considered a strategy based on sequential detection of SNPs and a decision tree (Figure 3).  203 
The phylogenetic analysis distinguished two major strain groups corresponding to those 204 
previously designated Type C and Type S (Figure 1). We identified a SNP (snp3842359), 205 
which could be detected using BsmB1 (Table 2) that would discriminate between these two 206 
groups. Type C strains have an ‘A’ and Type S strains either a ‘G’ or ‘C’ at base position 207 
3842359. This constituted the first step in the decision tree, the next step being determined 208 
according to whether the isolate was Type C or Type S (Figure 3).  209 
For further analysis of Type S strains, we identified a SNP (snp343677), which could be 210 
detected using AvaII that discriminated the Type S sub-groups Type I and Type III (Table 2, 211 
Figures 1 and 3). Additionally, snp3842359 also could be used to distinguish Type I and 212 
Type III strains since Type I have a ”G” and Type III have a “C” at base position 3842359 213 
(Figure 3), which could be detected by PCR amplification and sequencing of the product.  214 
The Type C group comprised the majority of the isolates and the high homogeneity within 215 
this group posed a challenge for identification of clade specifying SNPs. Firstly, SNP 216 
analysis was repeated with only the sequence data from the 115 Type C isolates (Figure 2) 217 
and the minimum number of SNPs required to distinguish between these 115 isolates was 218 
determined to be 41. We then considered three principal sub-groups designated Bison (as 219 
reported previously, 10) and A and B as shown in Figures 1 and 2. We identified a SNP 220 
(snp50173), which could distinguish the Bison group from both sub-groups A and B using 221 
ApoI (Table 2, Figures 1 and 3). This constituted step 2 in the decision tree (Figure 3). 222 
Within the Bison group, Indian Bison type could be differentiated from US Bison type using 223 
snp2327379 and further differentiation of the Indian bison type was possible using 224 
snp305277 (Table 2, Figure 3). Due to the limited number of Bison type strains available 225 
extensive verification of these SNPs was not possible in this study.  226 
10 
 
To further discriminate between Type C isolates in sub-groups A and B, we identified a SNP 227 
(snp4111202), which could be detected using FatI (Table 2, Figures 1 and 3). Due to the 228 
small number of isolates in sub-group B, we did not, at this stage, seek additional SNPs to 229 
further discriminate the isolates within this group. This constituted step 3 in the decision tree 230 
(Figure 3). 231 
Within the larger subgroup A, SNPs were identified that could discriminate ten groups 232 
(snp3879247, snp2939977, snp1932058, snp1327872, snp3844632, snp1966028, snp305277, 233 
snp4339946, snp2087274 and snp1686154, Tables 2 and 3, Figures 2 and 3). These SNPs 234 
were verified by sequencing of the PCR products and comparison of the sequences with the 235 
reference Map K10 strain. It was not possible to identify SNPs with specific restriction 236 
endonuclease sites for the clades differentiated using snp2939977 and snp1932058 but all 237 
other SNPs could be detected by restriction endonuclease analysis (Table 2). 238 
 239 
SNP validation and genotyping. For the validation of the selected SNPs comprising the 240 
decision tree (Figure 3), DNA from isolates belonging to Type C (Bison group: 241 
MAPMRI029, MAPMRI031, MAPMRI127, MAPMRI034, MAPMRI117 and MAPMRI026; 242 
Sub-group A: MAPMRI110, MAPMRI120  and MAPMRI027; Sub-group B: MAPMRI059, 243 
MAPMRI136 and MAPMRI091) and Type S (Type I: MAPMRI007and MAPMRI001; Type 244 
III: MAPMRI051, MAPMRI045 and MAPMRI047) (Figure 2) were used for amplifying 245 
products containing SNPs (as indicated in Figure 3) and the PCR products were digested with 246 
the correspondent restriction enzymes (Table 2). PCR products were also purified and 247 
sequenced to confirm SNPs. To assess the validity of the ten SNPs for discriminating the 248 
clades within Sub-group A, thirty isolates from the original panel of 115 sequenced strains 249 
were re-tested. These were selected to be representative of the ten different phylogenetic 250 
clades as shown in Figure 2 and were subjected to analyses for all 14 SNPs (Figure 3), all of 251 
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which were confirmed to be present. The Map isolates were grouped into SNP profiles as 252 
shown in Table 3 and Figure 3.  253 
A further 26 Map isolates (Table 1) not previously sequenced or typed using this SNP assay 254 
were genotyped using the 14 SNPs. These isolates belonged to four phylogenetic groups 255 
within the Sub-group A. Significantly, ten isolates from different geographic regions of 256 
United Kingdom with the same MIRU-VNTR and PFGE profile were classified into three 257 
different SNP profiles, one of which was not identified in the original phylogenetic analysis 258 
and therefore represented a new SNP profile (SNP11) (Table 3). Two UK isolates were 259 
identified to belong to the SNP1 profile, six isolates to SNP9 and two isolates to profile 260 
SNP11. The 16 Portuguese isolates were distributed among three phylogenetic groups: all the 261 
isolates from Azores were present in the same group identified by profile SNP3; two isolates 262 
from the same region in the north of Portugal were identified in the same phylogenetic group 263 
as six isolates from the United Kingdom (profile SNP2); and, the remaining four Portuguese 264 
isolates from the same region were found to belong to the new phylogenetic group together 265 
with the two DNAs from the United Kingdom (profile SNP11) (Table 1).  266 
 267 
Discriminatory power of SNP-based genotyping assay. The discriminatory power of the 268 
SNP-based assay was 0.8390 for the 56 isolates that were used for the validation of the assay. 269 
In order to compare the discriminatory power of the SNP assay with MIRU-VNTR analysis, 270 
we used the typing results for 46 isolates, which had been typed using both methods. The 271 
HGDI was calculated to be 0.8135 for the SNP assay and 0.6386 for MIRU VNTR. 272 
 273 
DISCUSSION 274 
Several methods have been used to characterize Map strains but they have some limitations. 275 
Techniques based on the analysis of total genomic DNA such as RFLP and PFGE require 276 
culture of the isolates to prepare moderate amounts of high quality DNA and are therefore 277 
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slow, can be technically demanding, labour intensive, hard to standardize and expensive. 278 
Furthermore, RFLP and PFGE can clearly distinguish between Type C and S but do not give 279 
sufficient discrimination within these strain types for detailed epidemiological studies. 280 
Techniques such as AFLP and RAPD employ PCR to detect smaller genomic DNA 281 
fragments but are less utilised for epidemiological studies due to difficulties in 282 
standardisation, reproducibility and limited discriminative power. Other typing methods 283 
based on repetitive sequences such as SSR and MIRU-VNTR are popular due to their ease of 284 
use and rapidity but are again limited with respect to their ability to discriminate within the 285 
two major strain types and the typing results may not reflect the evolutionary relationships 286 
between isolates (10; 12; 25; 26). 287 
 In this study a novel typing assay based on SNP analysis by PCR and restriction or 288 
sequencing of the amplified products was developed. This technique is easy to perform, is 289 
applicable to a small quantity of genomic DNA and is based on standard PCR and restriction 290 
endonuclease analysis. It was possible to refine the number of SNPs to a number manageable 291 
for routine laboratory procedures by adopting an approach based on sequential detection of 292 
SNPs via a decision tree. The SNP assay was highly discriminative, possessing a higher 293 
discriminatory power than MIRU-VNTR when applied to 46 Map isolates. 294 
SNP-based typing assays are particularly useful for monomorphic pathogens that exhibit 295 
limited genetic diversity. Furthermore, they have the advantage that they can be used to 296 
determine phylogenetic relationships, unlike techniques based on mobile or repetitive DNA 297 
elements, which interrogate a relatively small proportion of the mycobacterial genome and 298 
can exhibit homoplasy.  However, SNP discovery is subject to phylogenetic discovery bias 299 
(2), a phenomenon well described for M. tuberculosis (27) and Bacillus anthracis (28), and is 300 
most likely to be encountered where information is missing on strains geographically-301 
restricted or belonging to rare phylogenetic groupings. For this reason, we utilised a large 302 
collection of global isolates, which had been previously genotyped by classical molecular 303 
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tools (PFGE and MIRU-VNTR) to maximise genetic diversity and include representatives of 304 
all previously reported strain types. The SNPs identified in this study should provide the 305 
necessary means to unambiguously classify Map strains within this global framework. Even 306 
so, the composition of any panel of SNPs needs to be reviewed or augmented once additional 307 
groups of strains that were not included in the initial analysis are discovered. This has been 308 
illustrated in this study with the discovery of a new phylogenetic group represented by profile 309 
SNP 11 comprising six isolates when an additional uncharacterised 26 isolates were screened 310 
using the SNP assay. WGS needs to be performed and the sequence comparisons and SNP 311 
analysis repeated to determine the positions of these isolates within the phylogenetic tree and 312 
determine any additional SNPs that could be used to define the group. In this study, we 313 
concentrated on finding SNPs to differentiate within Type C strains in sub-group A. The SNP 314 
assay needs to be expanded to differentiate between strains within Type S, Bison type and 315 
Type C subgroup B, but WGS data from more strains belonging to these phylogenetic groups 316 
are required for SNP discovery to provide a phylogenetically robust framework for strain 317 
differentiation combined with sufficient discriminatory power for detailed genetic studies.  318 
SNPs have been described in previous studies that differentiate between the two major 319 
phylogenetic groups, Type S and Type C, and between Map strain Types I and III. A PCR-320 
REA assay described by Whittington et al. (29) based on a SNP at base position 223 in the 321 
IS1311 insertion sequence has been used extensively for discriminating between Type S and 322 
Type C strains. However, in a recent study (10) the IS1311-REA incorrectly identified strain 323 
MAPMRI074 as a Type S strain when WGS and SNP analysis clearly confirmed it to be 324 
Type C, suggesting that the C to T allelic variation at base pair position 223 in IS1311 325 
occurred after the initial divergence of Type C from Type S strains. The SNP identified in 326 
this study, snp3842359, and the corresponding restriction endonuclease BsmBI for PCR-REA 327 
SNP detection could provide a more reliable alternative assay for differentiating Type S and 328 
C strains.  329 
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IS1311 SNP analysis has also been used to distinguish Bison type strains from non-Bison 330 
Type C and Type S strains (30). In Bison-type strains, all copies of IS1311 have a “T” at base 331 
pair position 223, whereas the non-Bison Type C strains have one or more copies with a “C” 332 
or “T” at the same position. Copy number with respect to this allele is not always easy to 333 
assess and can be very variable (10). Snp50173 and the corresponding restriction 334 
endonuclease ApoI for PCR-REA SNP detection could provide an easier, alternative assay 335 
for discriminating Bison-type strains from other Type C strains. 336 
A study published by Castellanos and colleagues (17) developed a PCR-REA to detect a SNP 337 
present on the gyrB gene at base position 1626 that allowed discrimination of Type III from 338 
Type I and II strains. Additional SNPs in the gyrA gene were identified that could 339 
differentiate Types I and III from Type II. In our study it is possible to use only a single SNP 340 
to discriminate Type I, Type II and Type III based on the amplification and sequencing of a 341 
fragment containing the snp3842359 where in the same position of the genome Type I strains 342 
have a “G”, Type II have an “A” and Type III have a “C”. This is an improvement compared 343 
with the system previously reported.  344 
In conclusion, we developed a novel SNP-based genotyping assay based on the analysis of 14 345 
SNPs that can be used to characterize Map isolates within 14 phylogenetic groups with a 346 
higher discriminatory power compared to MIRU-VNTR assay and other typing methods. We 347 
adopted an approach based on sequential detection of SNPs and a decision tree based on 348 
PCR-restriction enzyme digestion to reduce the number of SNPs and required PCRs. This 349 
novel assay can overcome some issues regarding the genotyping of isolates characterized as 350 
Type I, Type III and Bison type. Continuous updating of genome sequences are needed in 351 
order to better characterize new phylogenetic groups and SNP profiles. The novel SNP assay 352 
is a  discriminative, simple, reproducible method and requires only basic laboratory 353 
equipment for the large-scale global typing of Map isolates. 354 
 355 
15 
 
Acknowledgements 356 
This work was supported by the Scottish Government Rural and Environment Science and 357 
Analytical Services Division. Célia Leão is a recipient of a PhD grant from “Fundação para a 358 
Ciência e a Tecnologia” SFRH/BD/62469/2009. 359 
 360 
Conflict of interest statement 361 
The authors declare that there are no conflicts of interest. 362 
 363 
References 364 
1. Naser SA, Sagramsingh SR, Naser AS, Thanigachalam S. 2014. Mycobacterium 365 
avium subspecies paratuberculosis causes Crohn’s disease in some inflammatory 366 
bowel disease patients. World J Gastroenterol 20:7403-7415. 367 
2. Achtman M. 2008. Evolution, population structure, and phylogeography of 368 
genetically monomorphic bacterial pathogens. Ann Rev Microbiol 62:53-70. 369 
3. Pavlik I, Horvathova A, Dvorska L, Bartl J, Svastova P, du Maine R, Rychlik I. 370 
1999. Standardisation of restriction fragment length polymorphism analysis for 371 
Mycobacterium avium subspecies paratuberculosis. J Microbiol Meth 38:155-167. 372 
4. Stevenson K, Hughes VM, de Juan L, Inglis NF, Wright F, Sharp JM. 2002. 373 
Molecular characterization of pigmented and non-pigmented isolates of 374 
Mycobacterium avium subspecies paratuberculosis. J Clin Microbiol 40:1798-1804. 375 
5. Motiwala AS, Strother M, Amonsin A, Byrum B, Naser SA, Stabel JR, Shulaw 376 
WP, Bannantine JP, Kapur V, Sreevatsan S. 2003. Molecular epidemiology of 377 
Mycobacterium avium subsp. paratuberculosis: Evidence for limited strain diversity, 378 
strain sharing, and identification of unique targets for diagnosis. J Clin Microbiol 379 
41:2015-2016. 380 
16 
 
6. Pillai SR, Jayarao BM, Gummo JD, Hue Jr EC, Tiwari D, Stabel JR, Whitlock 381 
RH. 2001. Identification and sub-typing of Mycobacterium avium subsp. avium by 382 
randomly amplified polymorphic DNA. Vet Microbiol 79:275-284. 383 
7. Thibault VC, Grayon M, Boschiroli ML, Hubbans C, Overduin P, Stevenson K, 384 
Gutierrez MC, Supply P, Biet F. 2007. New variable-number tandem-repeats 385 
markers for typing Mycobacterium avium subsp. paratuberculosis and M. avium 386 
strains: comparison with IS900 and IS1245 restriction fragment length polymorphism 387 
typing. J Clin Microbiol 45:2404-2410. 388 
8. Sevilla I, Li L, Amonsin A, Garrido J, Geijo MV, Kapur V, Juste RA. 2008. 389 
Comparative analysis of Mycobacterium avium subsp. paratuberculosis isolates from 390 
cattle, sheep and goats by short sequence repeat and pulsed-field gel electrophoresis 391 
typing. BMC Microbiol 8:204. 392 
9. Stevenson K, Àlvarez J, Bakker D, Biet F, de Juan L, Denham S, Dimareli Z, 393 
Dohmann K, Gerlach G-F, Heron I, Kopecna M, May L, Pavlik I, Sharp JM, 394 
Thibault VC, Willemsen P, Zadoks R, Greig A. 2009. Occurrence of 395 
Mycobacterium avium subspecies paratuberculosis across host species and European 396 
countries with evidence for transmission between wildlife and domestic ruminants. 397 
BMC Microbiol 9:212. 398 
10. Bryant JM, Thibault VC, Smith DGE, McLuckie J, Heron I, Sevilla IA,  Biet F, 399 
Harris SR, Maskell DJ, Bentley SD, Parkhill J, Stevenson K. 2015. Phylogenomic 400 
exploration of the relationships between strains of Mycobacterium avium subspecies 401 
paratuberculosis. BMC Genomics In press 402 
11. Bryant JM, Schürch AC, van Deutekom H, Harris SR, de Beer JL, de Jager V, 403 
Kremer K, van Hijum SA, Siezen RJ, Borgdorff M, Bentley SD, Parkhill J, van 404 
Soolingen D. 2013. Inferring patient to patient transmission of Mycobacterium 405 
tuberculosis from whole genome sequencing data. BMC Infect Dis 13:100. 406 
17 
 
12. Ahlstrom C, Barkema HW, Stevenson K, Zadoks RN, Biek R, Kao R, Trewby H, 407 
Haupstein D, Kelton DF, Fecteau G, Labrecque O, Keefe GP, McKenna SLB, 408 
Buck JD. 2015. Limitations of variable number of tandem repeat typing identified 409 
through whole genome sequencing of Mycobacterium avium subsp. paratuberculosis 410 
on a national and herd level. BMC Genomics 16:161. 411 
13. Stucki D, Malla B, Hostettler S, Huna T, Feldmann J, Yeboah-Manu D, Borrell 412 
S, Fenner L, Comas I, Coscollà M, Gagneux S. 2012. Two new rapid SNP-Typing 413 
methods for classifying Mycobacterium tuberculosis Complex into the main 414 
phylogenetic lineages. PLOS ONE 7:e41253. 415 
14. Joshi D, Harris NB, Waters R, Thacker T, Mathema B, Krieswirth B, Sreevatsan 416 
S. 2012. Single Nucleotide Polymorphisms in the Mycobacterium bovis genome 417 
resolve phylogenetic relationships. J Clin Microbiol 50:3853-3861. 418 
15. Octavia S, Lan R. 2007. Single-Nucleotide-Polymorphism typing and genetic 419 
relationships of Salmonella enterica Serovar Typhi Isolates. J Clin Microbiol 420 
45:3795–3801. 421 
16. Morelli G, Song Y, Mazzoni CJ, Eppinger M, Roumagnac P, Wagner DM, 422 
Feldkamp M, Kusecek B, Vogler AJ, Li Y, Cui Y, Thomson NR, Jombart T, 423 
Leblois R, Lichtner P, Rahalison L, Petersen JM, Balloux F, Keim P, Wirth T, 424 
Ravel J, Yang R, Carniel E, Achtman M. 2010. Yersinia pestis genome sequencing 425 
identifies patterns of global phylogenetic diversity. Nat Genet 42:1140-1143. 426 
17. Castellanos E, Aranaz A, Romero B, de Juan L, Àlvarez J, Bezos J, Rodríguez S, 427 
Stevenson K, Mateos A, Domínguez L. 2007. Polymorphisms in gyrA and gyrB 428 
genes among Mycobacterium avium subsp. paratuberculosis Type I, II, and III 429 
isolates. J Clin Microbiol 45:3439-3442. 430 
18 
 
18. Gastaldelli M, Stefani E, Lettini AA, Pozzato N. 2011. Multiplexed typing of 431 
Mycobacterium avium subsp. paratuberculosis Type I, II and III by Luminex xMAP 432 
suspension array. J Clin Microbiol 49:389-391. 433 
19. Wynne JW, Bellera C, Boyda V, Francisc B, Gwoźdźd J, Carajiasd M, Heinea 434 
HG, Wagnere J, Kirkwoode CD, Michalskia WP. 2014. SNP genotyping of animal 435 
and human derived isolates of Mycobacterium avium subsp. paratuberculosis. Vet 436 
Microbiol 172:479-485. 437 
20. Stevenson K. 2010. Comparative Differences between Strains of Mycobacterium 438 
avium subsp. paratuberculosis p126-137. In Behr MA, Collins DM (eds), 439 
Paratuberculosis Organism, Disease, Control. CAB International, Oxfordshire, UK. 440 
21. Stevenson K. 2015. Genetic diversity of Mycobacterium avium subsp. 441 
paratuberculosis and the influence of strain type on infection and pathogenesis: A 442 
review. Vet Res 46:64. 443 
22. Li L, Bannantine JP, Zhang Q, Amonsin A, May BJ, Alt D, Banerji N, Kanjilal 444 
S, Kapur V. 2005. The complete genome sequence of Mycobacterium avium 445 
subspecies paratuberculosis. Proc Natl Acad Sci USA 102:12344-12349. 446 
23. Wynne JW, Seeman T, Bulach D, Coutts SA, Talaat AM, Michalski WP. 2010. 447 
Re-sequencing the Mycobacterium avium subspecies paratuberculosis K10 genome: 448 
improved annotation and revised genome sequence. J Bacteriol 192:6319-6320.  449 
24. Hunter PR, Gaston MA. 1988. Numerical index of the discriminatory ability of 450 
typing systems: an application of Simpson’s index of diversity. J Clin Microbiol 451 
26:2465–2466. 452 
25. Castellanos E, de Juan L, Domínguez L, Aranaz A. 2012. Progress in molecular 453 
typing of Mycobacterium avium subspecies paratuberculosis. Res Vet Sci 92:169-454 
179.  455 
19 
 
26. Sevilla I, Garrido JM, Geijo M, Juste RA. 2007. Pulsed-field gel electrophoresis 456 
profile homogeneity of Mycobacterium avium subsp. paratuberculosis isolates from 457 
cattle and heterogeneity of those from sheep and goats. BMC Microbiol 7:18. 458 
27. Gagneux S, Small PM. 2007. Global phylogeography of Mycobacterium tuberculosis 459 
and implications for tuberculosis product development. Lancet Infect Dis 7:328-337. 460 
28. Pearson T, Busch JD, Ravel J, Read TD, Rhoton SD, U’Ren JM, Simonson TS, 461 
Kachur SM, Leadem RR, Cardon ML, Van Ert MN, Huynh LY, Fraser CM, 462 
Keim P. 2004. Phylogenetic discovery bias in Bacillus anthracis using single-463 
nucleotide polymorphisms from whole-genome sequencing. Proc Natl Acad Sci USA 464 
101:13536-13541.  465 
29. Whittington RJ, Marsh IB, Choy E, Cousins D. 1998. Polymorphisms in IS1311, 466 
an insertion sequence common to Mycobacterium avium and M. avium subsp. 467 
paratuberculosis, can be used to distinguish between and within these species. Mol 468 
Cell Probe 12:349-358. 469 
30. Whittington RJ, Marsh IB, Whitlock RH. 2001. Typing of IS1311 polymorphisms 470 
confirms that bison (Bison bison) with paratuberculosis in Montana are infected with 471 
a strain of Mycobacterium avium subsp paratuberculosis distinct from that occurring 472 
in cattle and other domesticated livestock. Mol Cell Probes 15:139-145. 473 
  474 
20 
 
Figure 1. Whole genome SNP-based phylogenetic tree of 133 Map isolates included in this 475 
study (strain sequence reference MAPMRI numbers are indicated). Previously described 476 
lineages and sub-groups A and B described in this study are highlighted in grey. 477 
 478 
Figure 2. Whole genome SNP-based phylogenetic tree of 115 Type C Map isolates (strain 479 
sequence reference MAPMRI numbers are indicated). Ten clades within the phylogenetic 480 
sub-group A can be distinguished by PCR and sequencing following the analysis of ten SNPs 481 
(grey boxes). Black circles indicate the 30 strains used for the validation of the method. 482 
 483 
Figure 3. Work flow with a schematic representation of the decision tree with the sequential 484 
numbered steps and restriction enzymes, SNPs positions, expected bases and SNP profiles 485 
obtained based on the SNPs analysis. * SNP that can be detected only by sequencing of the 486 
amplified product. # Bison type strains from India. § Bison type strains from US. 487 
  488 
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Table 1. Additional Map field isolates used for validation of SNP assay 
Isolate Host Geographic location Multiplex PFGE profile INMV profile* 
SNP profile 
(this study) 
F043531 cattle Northern Ireland (UK) 2.1 1 1 
F012398 cattle Cumbria (UK) 2.1 1 11 
F005713 cattle Wiltshire (UK) 2.1 1 11 
C217551 cattle Selkirkshire (UK) 2.1. 1 9 
C216785/2 cattle Mid Glamorgan (UK) 2.1 1 9 
C219376 cattle Shropshire (UK) 2.1 1 9 
C221325 cattle Gwynedd (UK) 2.1 1 9 
C524656 cattle Aberdeenshire (UK) 2.1 1 1 
C326442 cattle Ayr (UK) 2.1 1 9 
C216962/6 cattle Leicestershire (UK) 2.1 1 9 
C1 goat São Miguel (Azores, PT) ND ND 3 
C2 goat São Miguel (Azores, PT) ND ND 3 
C4 goat São Miguel (Azores, PT) ND ND 3 
22 
 
C7 goat São Miguel (Azores, PT) ND ND 3 
C9 goat São Miguel (Azores, PT) ND ND 3 
C11 goat São Miguel (Azores, PT) ND ND 3 
C13 goat São Miguel (Azores, PT) ND ND 3 
C14 goat São Miguel (Azores, PT) ND ND 3 
C16 goat São Miguel (PT) ND ND 3 
C4A4 goat São Miguel (Azores, PT) ND ND 3 
B1 cattle Vila do Conde (PT) ND 2 9 
B3 cattle Vila do Conde (PT) ND 2 9 
B13 cattle Póvoa do Varzim (PT) ND 2 11 
B18 cattle Póvoa do Varzim (PT) ND 2 11 
B21 cattle Póvoa do Varzim (PT) ND 2 11 
B22 cattle Póvoa do Varzim (PT) ND 2 11 
ND - not determined; UK – United Kingdom; PT – Portugal.  *Profile number assigned by INRA and published in an online database http://mac-
inmv.tours.inra.fr  
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Table 2. PCR primers and restriction endonucleases used in the SNP assay for this study 
SNP name Primer 
name 
Primer sequence (5’ to 3’) Annealing 
temperature 
(0C) 
Product 
size (bp) 
Enzyme Restriction results§ 
snp3842359* MAP_F1 CACCTGGCCAAGTACTACCA 63 528 BsmBI (A) Type C - 528 bp 
MAP_R1 GCGATGTCATGATGCTGCTG    (G/C) Type S - 312, 216 bp 
snp343677 TypeS_F AACACCAGGATCGCGTTCTT 65 511 AvaII (G) Type I - 297, 152, 62 bp 
 TypeS_R CAATTAGCGGTCGAGTCGTC     (A) Type III - 293, 218 bp 
snp50173 BisonF GGACGATTACTCGGTTCCAG 63 469 ApoI (T) Bison group - 226, 192, 51 bp 
 BisonR ACCCGTGTTCGGCTACCT    (G) Cattle group - 277, 192 bp  
snp4111202 SNP4_F GTCAGAAACATCCCGCCTTC 65 461 FatI (G) Type C sub-group A – 284, 177 bp 
 SNP4_R GTATTGAGTGAGGCAAGCGG    (C) Type C sub-group B - 461 bp 
snp3879247 SNP5_F GTTGATCGACAGCGAGTGC 64 465 BlpI/DdelI (C) – 227, 238 bp 
 SNP5_R GTGGTGTCCGAGGTGAACTT    (T) – 465 bp 
snp2939977 SNP6_F TATCTCCAAGGACGCATTCC 64 516 - - 
 SNP6_R CTGCCATGTCCGTCCTTAAT     
snp1932058 SNP7_F GGCTTGAAACTCCAACTGCT 63 452 - - 
 SNP7_R CGTCGTACATCCTCGTGGT     
snp1327872 SNP8_F GCGCTTGTTGTACAGGTTGA 64 528 AvaI/BsoBI (G) – 292, 171, 65 bp 
 SNP8_R TACGACGAAGACCCCGACTA    (T) – 463, 65 bp 
snp3844632 SNP9_F GATCGATGCGGAGCTCGT 64 457 FatI (G) – 457 bp 
 SNP9_R TGACAGGAAGGTCCATAGCC    (C) – 241, 217 bp 
snp1966028 SNP10_F GTCGAGGGCTTCCAGGTT 67 427 SapI/EarlI (A) – 427 bp 
 SNP10_R GTCTGAGGCCAGCGACAC    (C) – 246, 182 bp 
snp305277† SNP11_F CCATCCCGAGTTCAACAAGT 64 461 BspMI/BfuAI (G) – 310, 151 bp 
 SNP11_R ACTTGTCGGGGTTGTAGCTG    (A) – 461 bp 
snp4339946 SNP12_F AACCGCTCAAGGCGAAAG 64 464 BstEII (T) – 292, 172 bp 
 SNP12_R TCCCTTATCTGCGAAGTGCT    (A) – 464 bp 
snp2087274 SNP13_F CAGACCGAGCACCTCCTG 65 453 HpyAV (C) – 453 bp 
 SNP13_R CCGCGTTGAAGGATCTCAAG    (A) – 227, 226 bp 
snp1686154 SNP14_F GAATCCCCGGAACTGGTG 65 525 MscI (G) – 525 bp 
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 SNP14_R GCAGTCCAGATAACGGAACG    (A) – 284, 241 bp 
*SNP can also distinguish between Type I and III (Type I has a ”G” and Type III has a “C” at base position 3842359 detectable by sequencing the PCR product); †SNP 
can also distinguish between two phylogenetic subgroups of Bison group isolates (Figure 3); § in parenthesis is the expected base at the correspondent SNP 
position; - not applicable. 
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Table 3. SNP profiles of Type C Map isolates in phylogenetic sub-group A used in this study 
Phylogenetic group SNP 
profile 
No. 
isolates 
verified 
Base at SNP position* 
3
8
4
2
3
5
9
 
3
4
3
6
7
7
 
5
0
1
7
3
 
4
1
1
1
2
0
2
 
3
8
7
9
2
4
7
 
2
9
3
9
9
7
7
 
1
9
3
2
0
5
8
 
1
3
2
7
8
7
2
 
3
8
4
4
6
3
2
 
1
9
6
6
0
2
8
 
3
0
5
2
7
7
 
4
3
3
9
9
4
6
 
2
0
8
7
2
7
4
 
1
6
8
6
1
5
4
 
Reference base (K10)   A A G G C G G G G A G T C A 
Clade 1 1 7 A A G G C G A G G A G T C G 
Clade 2 2 1 A A G G C A G G G A G T C G 
Clade 3 3 11 A A G G T G G G G A G T C G 
Clade 4 4 2 A A G G C G G T G A G T C G 
Clade 5 5 1 A A G G C G G G C A G T C G 
Clade 6 6 1 A A G G C G G G G A A T C G 
Clade 7 7 1 A A G G C G G G G C G T C G 
Clade 8 8 1 A A G G C G G G G A G A C G 
Clade 9 9 16 A A G G C G G G G A G T A G 
Clade 10 10 9 A A G G C G G G G A G T C A 
new clade 11 6 A A G G C G G G G A G T C G 
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 Total no. 56               
* SNP position in the revised Map K10 sequence (Accession number: AE016958.1). 
Defining SNP base marked in bold type 
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